While the literature does seem to indicate that there is a strong relationship between SHP and ESA‐resistant anemia, treatment of SHP is primarily dictated by goals in PTH, vitamin D, calcium, and phosphorus levels; even these goals that dictate clinical practice are not always scientifically based[10]. The gene discussed is PTH; the disease is anemia.